Home
About Numira
Services
Products
Image Gallery
Publications
News
Events
Management Team
Contact Us
Career Opportunities
Related Links

Christopher Thibodeau, Vice President Sales & Marketing
cthibodeau@numirabio.com

Christopher joined the Numira Biosciences as the Vice President of Sales & Marketing in January of 2007. He will be responsible for Numira Biosciences’ worldwide sales & marketing initiatives. Prior to joining Numira Biosciences, Mr. Thibodeau served as National Director of Sales for US LABS, an industry leader in cancer diagnostic and genomic testing services, managing national sales development. He led a staff of over fifty managers and sales representatives including the national sales training program. Previously, he was responsible for corporate marketing of US LABS’ Hematology and Oncology product line helping to launch several innovative products and services in the genomics arena. Over his six year tenure with US LABS, starting at its infancy, he contributed to the company’s brand development, market share and revenue growth which ultimately attracted its acquisition by LabCorp, one the nation’s largest laboratory service providers. Before joining US LABS, Thibodeau held various sales and management positions at Ventana Medical Systems and Interspace Advertising. He has extensive experience in sales leadership and the marketing of innovative life science products and services. He graduated from East Stroudsburg University with a Bachelor of Arts Degree.


Scientific Advisory Board

Charles Keller, MD, Chairman of the Scientific Advisory Board, Co-Founder
ckeller@numirabio.com

Charles joined the Children's Cancer Research Institute at the University of Texas Health Science Center in January of 2005 with major faculty responsibilities as a Principal Investigator in Developmental Cancer Genetics and Therapeutics and Assistant Professor in the Department of Cellular and Structural Biology. Dr. Keller attended Tulane University where he received a degree in Biomedical Engineering prior to attending Baylor College of Medicine where he received his M.D. degree. After completing his internship and residency in Pediatrics at Texas Children's Hospital, Dr. Keller trained in Pediatric Hematology-Oncology at the University of Utah and as a post-doctoral fellow in Mario Capecchi's laboratory.

Dr. Keller is a board-certified pediatric hematologist oncologist specializing in the development of more effective, less toxic therapies for a type of childhood muscle cancer called rhabdomyosarcoma. In collaboration with other investigators of the Children's Oncology Group, Dr. Keller is investigating whether the genes thought to be responsible for the initial formation of rhabdomyosarcomas are also important when the disease progresses, thereby identifying targets for new medical therapies. As a major focus of his research, Dr. Keller is developing and studying a mouse model of the aggressive childhood muscle cancer, alveolar rhabdomyosarcoma. Using conditional genetics to temporally and spatially restrict Pax3:Fkhr oncogene expression to subsets of embryonic and post-natal muscle cell precursors, it is hoped that rhabdomyosarcomas can be understood in terms of their cell of origin while at the same time unraveling the step-by-step process of tumor formation, angiogenesis, and metastasis.

Chris Johnson, Ph.D. Scientific Advisory Board

Dr. Johnson is the Director of the Scientific Computing and Imaging Institute at the University of Utah where he is a Distinguished Professor of Computer Science and holds faculty appointments in the Departments of Physics and Bioengineering.  He founded the SCI research group in 1992 which has since grown to become the SCI Institute employing over 100 faculty, staff and students.

Professor Johnson serves on several international journal editorial boards, as well as on advisory boards to several national research centers. Among his current responsibilities Co-Director, The Center for Integrative Biomedical Computing (CIBC), Distinguished Professor of Computer Science, Research Professor of Bioengineering, Adjunct Professor of Physics, Faculty Member, Computational Engineering and Science (CES) Program, Faculty Member, Brain Institute, Co-Founder, Visual Influence Inc., Co-Editor, The Visualization Handbook.

Professor Johnson was awarded a Young Investigator's (FIRST) Award from the NIH in 1992, the NSF National Young Investigator (NYI) Award in 1994, and the NSF Presidential Faculty Fellow (PFF) award from President Clinton in 1995. In 1996 he received a DOE Computational Science Award and in 1997 received the Par Excellence Award from the University of Utah Alumni Association and the Presidential Teaching Scholar Award. In 1999, Professor Johnson was awarded the Governor's Medal for Science and Technology from Governor Michael Leavitt. In 2003 he received the Distinguished Professor Award from the University of Utah . In 2004 he was elected a Fellow of the American Institute for Medical and Biological Engineering and in 2005 he was elected a Fellow of the American Association for the Advancement of Science.

Jay Tsuruda, MD Scientific Advisory Board

Dr. Tsuruda has degrees in Biochemistry/Molecular Biology (BA, University of California , Santa Barbara ) and Medicine (MD, UC San Diego, School of Medicine ), Internship in Internal Medicine and Surgery ( Oregon Health Sciences University ) and Diagnostic Radiology Residency at UC San Diego. He is dual fellowship trained in Magnetic Resonance Imaging at Huntington Medical Research Institutes Pasadena and Neuroradiology at UC San Francisco. He has held multiple academic positions including UC San Francisco as Chief of NeuroMRI research and Attending Neuroradiologist, and similar positions at the Universities of Washington and Utah .  He is a Senior Member of the American Society of Neuroradiology.

Dr. Tsuruda has maintained an active research practice supported by the NIH for the study of diffusion MR, MR Angiography and high resolution vascular imaging, and is a reviewer for several medical journals. He has established an active practice in MR Neurography, is one of the co-founders of the Neurography Institute of Santa Monica, specializes in image guided intervention for neuromuscular disorders, and a co-patent holder in MR Neurography.

Dr. Tsuruda was a co-founder and member of the board of directors of Visual Influence of Salt Lake City, which provides software processing for large scale data sets, including medical imaging solutions for Confirma and Clario Medical Imaging in Seattle . 

Dr. Tsuruda has served on several large corporate medical advisory boards for General Electric, Amersham (now part of General Electric), Philips, Toshiba, as well as a smaller successful start up company, Confirma, in Kirkland WA (www.confirma.com). In the mid 1990s, he was a co-founder and member of the board of directors of UltraImage in Seattle , which specialized in the design and production of FDA approved radiofrequency coils for MRI, which eventually merged with Pathway Medical in Redmond WA (www.pathwaymedical.com).